Synergistic Enhancement of 5-Fluorouracil Chemotherapeutic Efficacy by Taurine in Colon Cancer Rat Model
Authors:
- Daniela Hartmann JornadaDJDaniela Hartmann Jornada
- Diogo BoreskiDiogo Boreski
- Diego Eidy ChibaDCDiego Eidy Chiba
- Denise LigeiroDLDenise Ligeiro
- Marcus Alexandre Mendes LuzMLMarcus Alexandre Mendes Luz
- Edmo Atique GabrielEGEdmo Atique Gabriel
- Cauê Benito ScarimCSCauê Benito Scarim
- Cleverton Roberto de AndradeCACleverton Roberto de Andrade
- Chung Man ChinChung Man Chin
Open Access
- 10 September 2024
- Vol. 16 (18) , 3047
Abstract
Colorectal cancer (CRC) is one of the top 10 most common cancers worldwide and caused approximately 10 million deaths in 2022. CRC mortality has increased by 10% since 2020 and 52.000 deaths will occur in 2024, highlighting the limitations of current treatments due to ineffectiveness, toxicity, or non-adherence. The widely used chemotherapeutic agent, 5-fluorouracil (5-FU), is associated with several adverse effects, including renal, cardiac, and hepatic toxicity; mucositis; and resistance. Taurine (TAU), an essential β-amino acid with potent antioxidant, antimutagenic, and anti-inflammatory properties, has demonstrated protective effects against tissue toxicity from chemotherapeutic agents like doxorubicin and cisplatin. Taurine deficiency is linked to aging and cancers such as breast and colon cancer. This study hypothesized that TAU may mitigate the adverse effects of 5-fluorouracil (5-FU). Carcinogenesis was chemically induced in rats using 1,2-dimethylhydrazine (DMH). Following five months of cancer progression, taurine (100 mg/kg) was administered orally for 8 days, and colon tissues were analyzed. The results showed 80% of adenocarcinoma (AC) in DMH-induced control animals. Notably, the efficacy of 5-FU showed 70% AC and TAU 50% while, in the 5-FU + TAU group, no adenocarcinoma was observed. No differences were observed in the inflammatory infiltrate or the expression of genes such as K-ras, p53, and Ki-67 among the cancer-induced groups whereas APC/β-catenin expression was increased in the 5FU + TAU-treated group. The mitotic index and dysplasia were increased in the induced 5-FU group and when associated with TAU, the levels returned to normal. These data suggest that 5-FU exhibits a synergic anticancer effect when combined with taurine.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) (2018/11079-0)
This publication has 63 references indexed in Scilit:
- A prognostic cuproptosis-related lncRNA predictive signature for bladder cancer patientsHuman Cell, 2023
- Analysis of clinical important of LncRNA-HOTAIR gene variations and ovarian cancer susceptibilityMolecular Biology Reports, 2020
- Taurine abrogates mammary carcinogenesis through induction of apoptosis in Sprague‐Dawley ratsJournal of Biochemical and Molecular Toxicology, 2018
- Long non-coding RNA SNHG15 interacts with and stabilizes transcription factor Slug and promotes colon cancer progressionCancer Letters, 2018
- Long noncoding RNA BC200 regulates cell growth and invasion in colon cancerThe International Journal of Biochemistry & Cell Biology, 2018
- Downregulation of the long non-coding RNA TUG1 is associated with cell proliferation, migration, and invasion in breast cancerBiomedicine & Pharmacotherapy, 2017
- Environmental Influences in the Etiology of Colorectal Cancer: the Premise of MetabolomicsCurrent Pharmacology Reports, 2017
- Aberrant crypt foci as precursors in colorectal cancer progressionJournal of Surgical Oncology, 2008
- Taurine Interaction with Neurotransmitter Receptors in the CNS: An UpdateNeurochemical Research, 2005
- Absence of p53 gene mutations in rat colon carcinomas induced by azoxymethaneCancer Letters, 1995